Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Fedegari opts for Wind River RTOS for sterilisation units

12-Jan-2011 - Mobile software developer Wind River says Fedegari Autoclavi has adopted its VxWorks real-time operating system (RTOS) for its Therma4 control systems for its industrial sterilisation machines.

Merck KGaA sets up Indian tech centre

04-Jan-2011 - Merck KGaA has opened a new centre in India to showcase its range of technology solutions to the country’s rapidly expanding pharmaceutical and cosmetics industries.

Latest M&As in the pharmaceutical space

04-Jan-2011 - in-Pharmatechnologist presents a roundup of the latest deals and acquisitions in the pharmaceutical sector with news from Optima, SPI and DPS Engineering.

DSM expands process R&D offering in deal with c-LEcta

16-Dec-2010 - DSM Pharmaceutical Products has expanded its portfolio of alcohol dehydrogenases in a licensing deal with German custom enzyme developer c-LEcta.

Takeda & Baxter aim to set up cell culture site in Japan

08-Dec-2010 - Takeda is collaborating with Baxter to establish a Vero cell-based influenza manufacturing facility in Japan and launch vaccines in the country.

Lanxess opens Indian IER to meet demand for ultra pure water

07-Dec-2010 - Lanxess has opened an ion exchange resin production facility in India to cater for growing pharmaceutical manufacturing sector demand for ultrapure water.

List of pharma sites vital to US security released by WikiLeaks

06-Dec-2010 - WikiLeaks has published a list of overseas biopharmaceutical facilities considered vital to US national security as part of its release of leaked diplomatic cables.

Drugmakers are blind to colours, say researchers

24-Nov-2010 - Drug manufacturers do not pay enough attention to the colour of their drugs, according to researchers examining the importance of aesthetics in pharmaceutical over-the-counter (OTC) products.

News in brief

EMD Millipore launches enhanced Mobius 3L CellReady Bioreactor

18-Nov-2010 - German pharmaceutical giant Merck's life science division, EMD Millipore, has launched its 'single-use' Mobius 3L CellReady Bioreactor, for use in the development and optimisation of cell culture processes.

Dissolution devise makes ‘dosage dumping’ a thing of the past, says Agilent

18-Nov-2010 - Agilent Technologies has launched its 708-DS Dissolution Apparatus, a quality control instrument that can be set up for manual or automated applications to measure the release rate of an API over time.

GEA ups Asian freeze-drying activity with BSGT purchase

17-Nov-2010 - GEA Pharma Systems stamps its authority in the Asian Pacific’s emerging freeze drying industry acquiring Beijing Sino-German Tianhe Technology (BGST).

ATMI acquires Artelis in ‘disposables’ deal

04-Nov-2010 - ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.

ATMI and Austar open packaging materials plant in China

26-Oct-2010 - ATMI opens new packaging plant in China; positions for growth of bioprocess business in Asia and sees modest growth of life sciences business in Q3.

Sanyo adds cost-effective GMP cell processing unit

25-Oct-2010 - Sanyo Biomedical is launching a cost-effective, space-saving stand-alone cell processing work station (CPWS) for GMP production.

Reaxa spin-off ADC Biotechnology talks new processing tech

21-Oct-2010 - A developmental purification system for Antibody-Drug-Conjugates will be launched by ADC Biotechnology (ADBC), a spin off from Reaxa, which promises reduced manufacturing costs for “magic bullet” cancer drugs.

News in brief

New industrial CPO grade launched to meet drug sector demand

21-Oct-2010 - Bio-Research Products (BRP) launches lower cost, industrial chloroperoxidase (CPO) for organic syntheses in pharmaceutical manufacturing.

News in brief

WR Grace’s acquisition of Synthetech approved by US Bankruptcy Court

19-Oct-2010 - Industrial catalysis firm WR Grace has been OKed to acquire fine chemicals group Synthetech by the US Bankruptcy Court.

Respiratory drugs a particular* opportunity for processing tech says Prosonix

19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.

Almac invests in biocatalysis lauding cost and environmental benefits

13-Oct-2010 - Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.

Pharmatek ‘roll’ out new equipment to expand GMP manufacturing capabilities

13-Oct-2010 - Pharmatek Laboratories has once again expanded service offerings at its San Diego, California facility by adding two roller compactors to its solid oral dosage form manufacturing capabilities.

European Centre for Chirality to open in December

13-Oct-2010 - New ‘chiral center’ in Belgium promises to help drug firms comply with regulatory demands for quality and accelerate registration of new compounds.

News in brief

GSK to cut 121 jobs at key Irish plant

07-Oct-2010 - GlaxoSmithKline has told its workforce that 55 jobs will be axed at its manufacturing base in Currabinny, Co Cork, and 66 jobs will be lost as a result of revised shift-working plans.

SP Scientific using Praxair tech to control lyophilisation

30-Sep-2010 - SP Scientific is combining its lyophilisation equipment with ControLyo from Praxair to enable precise control over the freeze-drying process.

News in brief

Chemically defined supplements boost Sheffield Bio-Science's product portfolio

29-Sep-2010 - Sheffield Bio-Science takes on responsibility for global sales, distribution and development of Girus Life Sciences’ chemically defined Regocel supplements.

News in brief

Life Technologies to out-license CHO cell lines recombinant proteins

20-Sep-2010 - Life Technologies has concluded license agreements, providing rights to its proprietary Chinese hamster ovary (CHO) cell lines for production of recombinant proteins used as therapeutic agents and vaccines.

Sign up for your free newsletter